Skip to main content

Table 3 Angiographic outcomes with quantitative coronary angiography data at 9 months follow-up *

From: Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea

  EES (Lesion n = 324) R-ZES (Lesion n = 240) P value
Number of patients 264 (65.2%) 181 (66.1%) 0.869
Before index procedure    
Lesion length, mm 20.33 ± 10.04 20.89 ± 8.89 0.528
Reference diameter, mm 2.88 ± 0.60 2.77 ± 0.50 0.038
Minimum lumen diameter, mm 0.73 ± 0.50 0.71 ± 0.53 0.769
Percent stenosis, % 80.73 ± 14.79 77.64 ± 17.24 0.024
After index procedure    
Total stent length, mm 27.03 ± 12.91 28.61 ± 12.88 0.153
Number of stents/lesion 1.20 ± 0.45 1.20 ± 0.43 0.889
Minimum lumen diameter, mm    
 In-stent 2.60 ± 0.48 2.53 ± 0.43 0.061
 In-segment 2.59 ± 0.50 2.50 ± 0.46 0.030
Percent stenosis, %    
 In-stent 13.03 ± 6.92 11.17 ± 6.26 0.001
 In-segment 12.60 ± 7.20 11.27 ± 7.53 0.037
Acute gain, mm    
 In-stent 1.89 ± 0.64 1.83 ± 0.56 0.284
 In-segment 1.87 ± 0.67 1.80 ± 0.60 0.237
Follow-up procedure    
Minimum lumen diameter, mm    
 In-stent 2.37 ± 0.66 2.23 ± 0.64 0.017
 In-segment 2.36 ± 0.66 2.20 ± 0.66 0.006
Percent stenosis, %    
 In-stent 20.65 ± 17.52 20.50 ± 19.23 0.925
 In-segment 19.41 ± 17.30 20.68 ± 19.19 0.431
Late lumen loss, mm    
 In-stent 0.24 ± 0.53 0.29 ± 0.58 0.267
 In-segment 0.23 ± 0.52 0.29 ± 0.64 0.248
Loss index    
 In-stent 0.19 ± 0.78 0.09 ± 0.57 0.129
 In-segment 0.15 ± 0.81 0.07 ± 0.99 0.093
Binary restenosis, %    
 In-stent 18 (5.8%) 15 (6.8%) 0.716
 In-segment 17 (5.6%) 15 (6.9%) 0.582
  1. * Among a total of 679 patients, angiographic follow-up was available in 65.5% of patients (445 patients with 561 lesions). Data are number (%), unless otherwise indicated. Plus-minus values are means ± SD.
  2. Abbreviations: EES everolimus-eluting stent, R-ZES Resolute zotarolimus eluting-stent.